Cyclosporine-induced coronary artery constriction - Dissociation between thromboxane release and coronary vasospasm

Journal of Heart and Lung Transplantation

Volumn 18, Issue 4, 1999, Pages 328-335

  Braun Dullaeus, Ruediger C ^a   Feussner, Markus ^a   Walker, Gerhard ^a   Hopmann, Heike ^a   Kraemer, Hans Joachim ^a   Grimminger, Friedrich ^a   Tillmanns, Harald ^a   Haberbosch, Werner ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; NITRIC OXIDE; THROMBOXANE;

ANIMAL TISSUE; ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SPASM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT;

EID: 0032941577     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(98)00041-2     Document Type: Article

References (43)

1. Kahan B.D. Cyclosporine. N Engl J Med. 321:1989;1725-1738.
2. Curtis J.J. Cyclosporine and posttransplant hypertension. J Am Soc Nephrol. 2:1992;S243-S245.
3. Tronc F., Carrier M., Pelletier L.C. Effects of cyclosporin injected at therapeutic doses into the renal and femoral arteries of the dog. Ann Chir. 45:1991;827-832.
4. Xue H., Bukoski R.D., McCarron D.A., Bennett W.M. Induction of contraction in isolated rat aorta by cyclosporine. Transplantation. 43:1987;715-718.
5. Carrier M., Tronc F., Stewart D., Pelletier L.C. Dose-dependent effect of cyclosporin on renal arterial resistance in dogs. Am J Physiol. 261:1991;H1791-H1796.
6. Lanese D.M., Conger J.D. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest. 91;1993:2144-2149
7. Mason J, Muller-Schweinitzer E, Dupont M et al. Cyclosporine and the renin-angiotensin system. Kidney Int (suppl.) 1991;32:S28-32.
8. Auch-Schwelk W., Duske E., Hink U., Betz M., Unkelbach M., Fleck E. Vasomotor responses in cyclosporin A-treated rats after chronic angiotensin blockade. Hypertension. 23:1994;832-837.
9. Kupferman J.C., Beaudoin R., Carr R., et al. Activation of the renal renin-angiotensin system by cyclosporine A and FK 506 in the rat. Transplant-Proc. 26:1994;2891-2893.
10. Gallego M.J., Garcia-Villalon A.L., Lopez-Farre A.J., et al. Mechanisms of the endothelial toxicity of cyclosporin A. Role of nitric oxide, cGMP, and Ca2+. Circ Res. 74:1994;477-484.
11. Roullet J.B., Xue H., McCarron D.A., Holcomb S., Bennett W.M. Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest. 93:1994;2244-2250.
12. Chiu P.J., Vemulapalli S., Sabin C., Rivelli M., Bernardino V., Sybertz E.J. Sympathoadrenal stimulation, not endothelin, plays a role in acute pressor response to cyclosporine in anesthetized rats. J Pharmacol Exp Ther. 261:1992;994-999.
13. Carrier M., Tronc F., Pelletier L.C., Latour J.G. Role of thromboxane and angiotensin in cyclosporine-induced renal vasoconstriction in the dog. J Heart Lung Transplant. 12:1993;851-855.
14. Grieve E.M., Hawksworth G.M., Simpson J.G., Whiting P.H. The reversal of experimental cyclosporin A nephrotoxicity by thromboxane synthetase inhibition. Biochem Pharmacol. 45:1993;1351-1354.
15. Mason J. The pathophysiology of Sandimmune (cyclosporine) in man and animals. Pediatr Nephrol. 4:1990;554-574.
16. de Deckere E.A., Nugteren D.H., Ten Hoor F. Prostacyclin is the major prostaglandin released from the isolated perfused rabbit and rat heart [letter]. Nature. 268:1977;160-163.
17. Giannessi D., Lazzerini G., Sicari R., DeCaterina R. Vasoactive eicosanoids in the rat heart clues to a contributory role of cardiac thromboxane to post-ischaemic hyperaemia . Pharmacol Res. 26:1992;341-356.
18. Byrne J.G., Appleyard R.F., Sun S.C., et al. Cardiac-derived thromboxane A2. An initiating mediator of reperfusion injury? J Thorac Cardiovasc Surg. 105:1993;689-693.
19. Mest H.J., Ponicke K., Heinroth-Hoffmann I., Meissner N., Giessler C. Relevance of mediators to cardiac parameters of isolated anaphylactic guinea-pig heart. Prostaglandins Leukot Essent Fatty Acids. 53:1995;21-29.
20. Laczkovics A., Havel M., Teufelsbauer H., Horvath R., Schreiner W., Wolner E. Cyclosporin-A induced heart failure after orthotopic heart transplantation. J Thorac Cardiovasc Surg. 35:1987;83-86.
21. Siostrzonek P., Teufelsbauer H., Kreiner G., et al. Relief of diastolic cardiac dysfunction after cyclosporine withdrawal in a cardiac transplant recipient. Eur Heart J. 14:1993;859-861.
22. Schuler S., Hetzer R., Warnecke H., et al. Failure of the transplanted heart without rejection-cardiotoxic effect of cyclosporine A? Eur Surg Res. 17:(suppl I):1985;71.
23. Sudhir K., MacGregor J.S., DeMarco T., et al. Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteries. Circulation. 90:1994;3018-3023.
24. Khalil A, Carrier M, Latour JG, Pelletier. Cyclosporin A-induced coronary artery vasoconstriction through myogenic and endothelium-dependent mechanisms. Circ Res 1996;94(suppl II):II-308-11.
25. Krebs H.A., Henseleit K. Untersuchungen ueber die Harnstoffbildung im Tierkörper. Hoppe-Seyler's Zeits Physiol Chemie. 210:1932;33-66.
26. Doering HJ, Dehnert H. The isolated perfused warm-blooded heart according to Langendorff. (1st ed.). March: Biomesstechnik-Verlag, 1988.
27. Langendorff O. Untersuchungen am ueberlebenden Saeugetierherzen. Arch Gen Physiol. 230:1895;183-186.
28. Kraemer H.-J., Stevens J., Seeger W. Analysis of 2- and 3-series prostanoids by post-HPLC ELISA. Analytical Biochemistry. 214:1993;535-543.
29. Linssen M.C., Engels W., Lemmens P.J., et al. Production of arachidonic acid metabolites in adult rat cardiac myocytes, endothelial cells, and fibroblast-like cells. Am J Physiol. 264:1993;H973-H982.
30. Zoja C., Furci L., Ghilardi F., Zilio P., Benigni A., Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest. 55:1986;455-462.
31. Mankad P., Spatenka J., Slavik Z., O'Neil G., Chester A., Yacoub M. Acute effects of cyclosporine and cremophor EL on endothelial function and vascular smooth muscle in the isolated rat heart. Cardiovasc Drugs Ther. 6:1992;77-83.
32. Carrier M., Tronc F., Stewart D., Nattel S., Pelletier L.C. Blockade of cyclosporine-induced vasoconstriction by the calcium channel blocker diltiazem in dogs. J Thorac Cardiovasc Surg. 106:1993;487-490.
33. De-Nicola L., Thomson S.C., Wead L.M., Brown M.R., Gabbai F.B. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest. 92:1993;1859-1865.
34. Gallego M.J., Lopez-Farre A., Riesco A., et al. Blockade of endothelium-dependent responses in conscious rats by cyclosporin A effect of L-arginine . Am J Physiol. 264:1993;H708-H714.
35. Rooth P., Dawidson I., Diller K., Taljedal I.B. Protection against cyclosporine-induced impairment of renal microcirculation by verapamil in mice. Transplantation. 45:1988;433-437.
36. Davidson I., Rooth P., Fry W.R., et al. Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil. Transplantation. 48:1989;575-580.
37. Kirk A.J.B., Omar I., Bateman D.N., Dark J.H. Cyclosporine-associated hypertension in cardiopulmonary transplantation. The beneficial effect of nifedipine on renal function. Transplantation. 48:1989;428-430.
38. Kingma I., Harmsen E., ter-Keurs H.E., Benediktsson H., Paul L.C. Cyclosporine-associated reduction in systolic myocardial function in the rat. Int J Cardiol. 31:1991;15-22.
39. Verbeke M., Van de Voorde J., de Ridder L., Lameire N. Functional analysis of vascular dysfunction in cyclosporin treated rats. Cardiovasc Res. 28:1994;1152-1156.
40. Lodge N.J. Direct vasoconstrictor effects of sandimmune (cyclosporine A) are mediated by its vehicle cremophor EL inhibition by the thromboxane A2/prostaglandin endoperoxide receptor antagonist ifetroban . J Pharmacol Exp Ther. 271:1994;730-734.
41. Bowers V.D., Locker S., Ames S., Jennings W., Corry R.J. The hemodynamic effects of cremophor-EL. Transplantation. 51:1991;847-850.
42. Beserab A., Jarell B.E., Hirsch S., Carabasi R.A., Cressman M.D., Green P. Use of the isolated perfused kidney model to assess the acute pharmacologic effects of cyclosporine and its vehicle, cremophor EL. Transplantation. 44:1987;195-201.
43. Weir M.R., Klassen D.K., Shen S.Y., Sullivan D., Buddemeyer E.U., Handwerger B.S. Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans. Transplantation. 49:1990;41-47.